X0202 SCHEDULE 13G/A 0001910025-26-000004 0001910025 XXXXXXXX LIVE 2 Common Stock, $0.0001 par value per share 03/31/2026 0001817229 VOR BIOPHARMA INC. 929033207 500 Boylston Street Suite 1350 Boston MA 02116 Rule 13d-1(c) Qiming Venture Partners VIII-HC, L.P. E9 1089767.00 0.00 1089767.00 0.00 1089767.00 2.0 PN Note to Row (11): The percentage is calculated based on 54,185,582 shares of Common Stock outstanding on March 31, 2026, as per the information provided by the Issuer. Qiming Venture Partners VIII Investments, LLC E9 910172.00 0.00 910172.00 0.00 910172.00 1.7 OO Note to Row (11): The percentage is calculated based on 54,185,582 shares of Common Stock outstanding on March 31, 2026, as per the information provided by the Issuer. Qiming GP VIII, LLC E9 910172.00 0.00 910172.00 0.00 910172.00 1.7 OO Note to Row (5) (7) and (9): As of the date of this Schedule 13G/A filing, Qiming GP VIII, LLC is the general partner of Qiming Venture Partners VIII, L.P. and Qiming VIII Strategic Investors Fund, L.P., which are the members of the Qiming Venture Partners VIII Investments, LLC with 99.50% and 0.50% equity interest in Qiming Venture Partners VIII Investments, LLC, respectively. Note to Row (11): The percentage is calculated based on 54,185,582 shares of Common Stock outstanding on March 31, 2026, as per the information provided by the Issuer. Qiming GP VIII-HC, LLC E9 1089767.00 0.00 1089767.00 0.00 1089767.00 2.0 HC OO Note to Row (5) (7) and (9): As of the date of this Schedule 13G/A filing, Qiming GP VIII-HC, LLC is the general partner of Qiming Venture Partners VIII-HC, L.P. Note to Row (11): The percentage is calculated based on 54,185,582 shares of Common Stock outstanding on March 31, 2026, as per the information provided by the Issuer. VOR BIOPHARMA INC. 500 Boylston Street, Suite 1350, Boston, MA, 02116. Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"), Qiming Venture Partners VIII-HC, L.P. ("QVP VIIIHC"), Qiming GP VIII, LLC, Qiming GP VIII-HC, LLC (collectively, the "Reporting Persons"). The registered address of each of the Reporting Persons is PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. All Reporting Persons are organized in Cayman Islands. Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of securities of the Issuer beneficially owned by such Reporting Person and is incorporated by reference. Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of securities of the Issuer beneficially owned by such Reporting Person and is incorporated by reference. The information set forth in Row (5) of the cover page for each of the Reporting Person is incorporated herein by reference. The information set forth in Row (6) of the cover page for each of the Reporting Person is incorporated herein by reference. The information set forth in Row (7) of the cover page for each of the Reporting Person is incorporated herein by reference. The information set forth in Row (8) of the cover page for each of the Reporting Person is incorporated herein by reference. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 99.1 Joint Filing Agreement, dated as of November 5, 2025 (incorporated by reference to Exhibit A to the Reporting Persons' Schedule 13G filed with the SEC on November 5, 2025). https://www.sec.gov/Archives/edgar/data/1817229/000095010325014354/dp237001_exa.htm Qiming Venture Partners VIII-HC, L.P. /s/ Holan Lam 05/06/2026 Qiming Venture Partners VIII Investments, LLC /s/ Holan Lam 05/06/2026 Qiming GP VIII, LLC /s/ Holan Lam 05/06/2026 Qiming GP VIII-HC, LLC /s/ Holan Lam 05/06/2026